BD Biosciences, Systems & Reagents recalls CD8 (Leu-2a) PE (In vitro diagnostic), Catalog number 340046. Hematology: Single color direct immunofluorescence reagen…
- Recall date
- December 19, 2014
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1000-2015
- FDA classification
- Class II
- Brand / firm
- BD Biosciences, Systems & Reagents
- Sold / distributed
- Worldwide distribution. US Nationwide including Puerto Rico, China, Brazil, Japan, Guatemala, India, New Zealand, Australia, Canada, Thailand, Chile and Malaysia.
Why it was recalled
One lot of CD8 PE is contaminated with CD4 FITC and may cause an unexpected staining pattern and incorrect patient data.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
CD8 (Leu-2a) PE (In vitro diagnostic), Catalog number 340046. Hematology: Single color direct immunofluorescence reagent for enumerating percentages of mature human suppressor/cytotoxic (CD8+) lymphocytes in erythrocyte-lysed whole blood or peripheral blood mononuclear cell suspensions.
Get recall alerts
Free email alert whenever BD Biosciences, Systems & Reagents has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: BD Biosciences, Systems & Reagents